SARS-CoV-2 感染和抗病毒策略:进展和局限性

Vinicius Cardoso Soares1,2,3, Isabela Batista Gonçalves Moreira1,2,3, Suelen Silva Gomes Dias1,2

  • 1Laboratory of Immunopharmacology, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro 21040-361, Brazil.

Viruses
|August 28, 2025
PubMed
概括

针对SARS-CoV-2的直接作用抗病毒药物可以降低疾病的严重程度,但面临病毒耐药性等挑战. 包括组合疗法在内的新策略对于有效的COVID-19治疗和全球接入至关重要.